Clinical Trial Update: Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer

View source ↗

Summary

This document reports on a terminated clinical trial evaluating predictors of response and toxicity in patients with breast cancer treated with paclitaxel and b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Taxol (paclitaxel)

Snippet

Sponsor: Hoosier Cancer Research Network | Conditions: Breast Cancer | Status: TERMINATED